The Valley Desk

NCT02475213 · Interventional trial

Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer

Overall registry status Completed

Phase 1

Conditions Head and Neck Cancer, Melanoma, Non Small Cell Lung Cancer, Urothelial Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov